Latest News
From the Journals
Children’s share of new COVID-19 cases is on the rise
“Unclear how much of the increase in child cases is due to increased testing capacity,” AAP says.
Feature
Pandemic poses new challenges for rural doctors
But physicians are adapting and still finding joy in treating patients.
Conference Coverage
Lower rituximab doses may be as effective, safer in MS
Adverse effects – particularly frequency of infection – were increased in the high-dose group.
Conference Coverage
Prior autoimmunity does not predict adverse events of alemtuzumab
Rare but serious and possibly life-threatening autoimmune events that have recently been linked to the drug.
Conference Coverage
B-cell test predicts alemtuzumab autoimmunity in MS
A higher percentage of total B cells, and in particular plasmablasts, could be a very predictive biomarker for autoimmunity after alemtuzumab...
Latest News
J&J’s one-shot COVID-19 vaccine advances to phase 3 testing
J&J’s vaccine is unusual in that it will be tested based on a single dose, while other advanced candidates have been tested in two-dose...
Latest News
CDC playbook prepares states for rollout of COVID-19 vaccine if one is approved
The agency has asked states to submit plans for vaccine distribution by mid-October.
Latest News
Three major COVID vaccine developers release detailed trial protocols
Typically, manufacturers guard the specifics of preclinical vaccine trials. This rare move follows calls for greater transparency.
Conference Coverage
Vascular dementia risk particularly high in type 2 diabetes
A 35% higher risk for vascular dementia was seen in people with type 2 diabetes versus those without; other dementia types were increased or...
Feature
More female specialists, but gender gap persists in pay, survey finds
The gap in specialists narrowed slightly.
Feature
Signs of an ‘October vaccine surprise’ alarm career scientists
If the executive branch were to overrule the FDA’s scientific judgment, a vaccine of limited efficacy and, worse, unknown side effects could be...